Trial record 2 of 2 for:    vytorin and type 1 diabetes

Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01185236
Recruitment Status : Unknown
Verified August 2010 by Seoul National University Hospital.
Recruitment status was:  Not yet recruiting
First Posted : August 19, 2010
Last Update Posted : August 19, 2010
Merck Sharp & Dohme Corp.
Information provided by:
Seoul National University Hospital

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : August 2011
  Estimated Study Completion Date : August 2011

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 October 25, 2011
(Canceled - Date Unknown)
November 22, 2011
December 23, 2011